Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices in elders of gerocomium.

Detailed Description
-----------------
Respiratory diseases are still increasing in the elderly population. The fluttering mucus clearance technique is expected to be a physical assisting therapy enhancing airway secretion clearance but needs more clinical randomized, controlled trial evidence.

Official Title
-----------------
Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function

Conditions
-----------------
Pulmonary Disease

Intervention / Treatment
-----------------
* Device: flutter mucus clearance device


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: available to perform the device, the elders in geracomium male and female aging 85 years or more Exclusion Criteria: not available to perform the procedure untreated pneumothorax diffusion interstitial lung disease acute coronary syndrome third stage hypertension advanced cancer severe heart, liver, renal, blood system and endocrine system dysfunction noninvasive mechanical ventilation active hemoptysis

Ages Eligible for Study
-----------------
Minimum Age: 85 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| No Intervention: control group<br> | |
| Experimental: intervention<br>Intervention group were given flutter valve mucus clearance devices to do pulmonary function exercise | Device: flutter mucus clearance device<br>* five minutes every sessions, three sessions per day<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher) |  | up to 28 days | 
| MPEF,Mean Peak Expiratory Flow | indicators of pulmonary function, for example, PEF(unit of measurement:Liter per minute) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study. | up to 28 days | 
| FEV1, Forced Expiratory Volume at First Second | indicators of pulmonary function, for example, FEV1(unit of measurement:Liter) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study. | up to 28 days | 
| FVC, Forced Vital Capacity | indicators of pulmonary function, for example, FVC(unit of measurement:Liter) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study. | up to 28 days | 
| FEV1/FVC%, the Ratio of FEV1 to FVC | indicators of pulmonary function, All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study. | up to 28 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of Cases With Antibiotics Therapy | antibiotics therapy is the indicators of pulmonary infection | up to 28 days | 
| Number of Cases With Hospital Visit |  | up to 28 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
geriatric, pulmonary disease, flutter, sputum, physical therapy techniques